Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liyan Xue

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
The Journal of Pathology|January 11, 2014
Identification of ZDHHC14 as a novel human tumour suppressor geneMarc Yeste-Velasco, Xueying Mao, Richard Grose, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2025
Evaluating CSPG4 expression in esophageal basaloid squamous cell carcinoma and conventional squamous cell carcinoma: a multi-institutional retrospective study in ChinaDongxian Jiang, Chen Xu, Yan Li, et al.
Cancer Cell|December 30, 2022
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinomaZhihua Liu, Yahui Zhao, Pengzhou Kong, et al.
Nature Medicine|July 2, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trialJianjun Qin, Liyan Xue, Anlin Hao, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
The Journal of Pathology|January 11, 2014
Identification of ZDHHC14 as a novel human tumour suppressor geneMarc Yeste-Velasco, Xueying Mao, Richard Grose, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2025
Evaluating CSPG4 expression in esophageal basaloid squamous cell carcinoma and conventional squamous cell carcinoma: a multi-institutional retrospective study in ChinaDongxian Jiang, Chen Xu, Yan Li, et al.
Cancer Cell|December 30, 2022
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinomaZhihua Liu, Yahui Zhao, Pengzhou Kong, et al.
Nature Medicine|July 2, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trialJianjun Qin, Liyan Xue, Anlin Hao, et al.
Pageof 18